Advertisement
Screener

Treace Medical Concepts, Inc. (TMCI) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value

2.8 / 5 stars · 68/120 Roast Me

Treace Medical Concepts, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value

Treace Medical Concepts, Inc. (TMCI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value of $500000.00 per share for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-25.

Discontinued › Notes › Share-Based Payment Arrangement, Disclosure

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue · last filed 2021-05-25

  • Treace Medical Concepts, Inc. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for the quarter ending 2021-03-31 was $500000.00, a 25.00% increase year-over-year.
  • Treace Medical Concepts, Inc. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for the quarter ending 2020-03-31 was $400000.00.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 3 month
2021-03-31$500000.00
10-Q · filed 2021-05-25
2020-03-31$400000.00
10-Q · filed 2021-05-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Mobia Medical, Inc. (MOBI)United States$0.293B
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
Embecta Corp. (EMBC)United States$0.319B2.10
Cytosorbents Corp (CTSO)United States$0.274B-1.29
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
SHOULDER INNOVATIONS, INC. (SI)United States$0.355B
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39